Efficacy of trabectedin in malignant solitary fibrous tumors: a retrospective analysis from the French Sarcoma Group

@inproceedings{Khalifa2015EfficacyOT,
  title={Efficacy of trabectedin in malignant solitary fibrous tumors: a retrospective analysis from the French Sarcoma Group},
  author={Jonathan Khalifa and Monia Ouali and L{\'e}onor Chaltiel and Sophie Le Guellec and Axel Le Cesne and Jean-Yves Blay and Philippe Cousin and Lo{\"i}c Chaigneau and Emmanuelle Bompas and S Piperno-neumann and Binh Bui-Nguyen and Mar{\'i}a R{\'i}os and J. P. Delord and Nicolas Penel and Christine Chevreau},
  booktitle={BMC Cancer},
  year={2015}
}
Advanced malignant solitary fibrous tumors (SFTs) are rare soft-tissue sarcomas with a poor prognosis. Several treatment options have been reported, but with uncertain rates of efficacy. Our aim is to describe the activity of trabectedin in a retrospective, multi-center French series of patients with SFTs. Patients were mainly identified through the French RetrospectYon database and were treated between January 2008 and May 2013. Trabectedin was administered at an initial dose of 1.5 mg/m2, q3… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS
7 Extracted Citations
34 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 34 references

the ANGIOTAX Study

  • N Penel, BN Bui, +4 authors angiosarcoma et al. Phase II trial of weekly paclitaxel for unresectable
  • J Clin Oncol. 2008;26:5269–74. Submit your next…
  • 2015

Similar Papers

Loading similar papers…